Health
Nanobody could be used as antiviral treatment against COVID-19 – Drug Target Review
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Posted: 4 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have found a nanobody named Ty1 that neutralises SARS-CoV-2 by attaching itself to the Spike protein of COVID-19.
Researchers have identified a small neutralising antibody, a so-called nanobody, that they say has the capacity to block SARS-CoV-2 from entering human cells. The researchers believe this nanobody has the potential to be developed as an antiviral treatment against COVID-19.
The study was c…
-
General21 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General19 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News23 hours agoBrisbane bands unite to help bassist’s cancer fight
-
Noosa News24 hours agoBoat crash in Helensvale on the Gold Coast leaves man with life-threatening burns and another one injured